Guggenheim Capital’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-821
| Closed | -$267K | – | 1934 |
|
2022
Q3 | $267K | Sell |
821
-44
| -5% | -$14.3K | ﹤0.01% | 1699 |
|
2022
Q2 | $228K | Sell |
865
-77
| -8% | -$20.3K | ﹤0.01% | 1893 |
|
2022
Q1 | $283K | Buy |
942
+49
| +5% | +$14.7K | ﹤0.01% | 1909 |
|
2021
Q4 | $315K | Buy |
893
+28
| +3% | +$9.88K | ﹤0.01% | 1846 |
|
2021
Q3 | $221K | Sell |
865
-20
| -2% | -$5.11K | ﹤0.01% | 2027 |
|
2021
Q2 | $589K | Buy |
885
+40
| +5% | +$26.6K | ﹤0.01% | 1767 |
|
2021
Q1 | $733K | Buy |
845
+403
| +91% | +$350K | ﹤0.01% | 1531 |
|
2020
Q4 | $410K | Sell |
442
-1,721
| -80% | -$1.6M | ﹤0.01% | 1709 |
|
2020
Q3 | $2.22M | Sell |
2,163
-596
| -22% | -$613K | 0.02% | 844 |
|
2020
Q2 | $2.8M | Buy |
2,759
+505
| +22% | +$512K | 0.02% | 735 |
|
2020
Q1 | $1.96M | Sell |
2,254
-442
| -16% | -$384K | 0.02% | 795 |
|
2019
Q4 | $2.89M | Buy |
2,696
+241
| +10% | +$258K | 0.02% | 888 |
|
2019
Q3 | $2.27M | Sell |
2,455
-51
| -2% | -$47.2K | 0.02% | 959 |
|
2019
Q2 | $2.83M | Buy |
2,506
+9
| +0.4% | +$10.2K | 0.02% | 899 |
|
2019
Q1 | $3.39M | Sell |
2,497
-78
| -3% | -$106K | 0.03% | 822 |
|
2018
Q4 | $2.98M | Sell |
2,575
-365
| -12% | -$422K | 0.03% | 831 |
|
2018
Q3 | $4.47M | Buy |
2,940
+80
| +3% | +$121K | 0.03% | 782 |
|
2018
Q2 | $4.48M | Sell |
2,860
-122
| -4% | -$191K | 0.03% | 791 |
|
2018
Q1 | $3.44M | Sell |
2,982
-270
| -8% | -$312K | 0.01% | 1245 |
|
2017
Q4 | $3.85M | Buy |
3,252
+2,861
| +732% | +$3.39M | 0.01% | 1186 |
|
2017
Q3 | $524K | Buy |
+391
| New | +$524K | ﹤0.01% | 2371 |
|